Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
3/10/2025
Nona Bio Launches AI-Assisted Drug Discovery Platform Hu-mAtrIx
3/7/2025
Enhua Pharma Acquires 10.4% Stake in NeuroThree with $3.5M Investment...
3/6/2025
Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline
3/6/2025
Bayer Expands Innovation in China with New E-Town Center
3/4/2025
Bioray's BR111: Pioneering Dual-Epitope ADC for ROR1-Positive Cancers
3/4/2025
Insilico and Tenacia Announce Research Collaboration for CNS Drug Disc...
3/4/2025
Amoytop's Strategic Acquisition of Skyline Assets Marks Expansion into...
3/4/2025
Raziel and Fosun's JuveStar Launch Phase 3 Trial in China for RZL-012
2/28/2025
SciClone Secures Rights to Eisai's Tasurgratinib for Greater China
2/28/2025
Duality Biologics Withdraws Hong Kong IPO Plans Amidst Strategic Partn...
2/27/2025
Takeda Expands Partnership with BridGene to Tackle Hard-to-Drug Target...
2/27/2025
HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies
2/25/2025
OS Therapies Launches Subsidiary to Seek ADC Joint Ventures in US and ...
2/25/2025
Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...
2/25/2025
Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...
2/21/2025
India Can Surpass China in Drug Discovery, Says Biocon Chief
2/21/2025
China Unveils 2025 Action Plan to Boost Foreign Investment in Biotech ...
2/21/2025
FibroGen Sells China Subsidiary to AstraZeneca in $160 Million Deal
2/20/2025
Chimigen Secures CNY100M+ in Pre-A Financing to Advance Cancer and Hep...
2/19/2025
Genuine Biotech Submits Second IPO Application amid Hong Kong Market R...
2/19/2025
Pharma Industry Faces Uncertainty Amid Potential U.S. Tariffs on Chin...
2/19/2025
CSPC Pharma Partners with Radiance for Global Development of Anticance...
2/18/2025
WuXi XDC in Strategic Transformation through Ownership Shift and Capit...
2/18/2025
META Pharmaceuticals Completes Series A1 Financing Led by XtalPi
2/18/2025
Polymed Licenses IRAK4-Targeting Protein Degrader HPB-143 to Photys
2/18/2025
Zydus Partners with Beihai to Launch BEIZRAY in the U.S.
2/18/2025
QL Biopharma Secures ¥100M Series C Financing to Advance Treatments f...
2/17/2025
Aurobindo Pharma to Begin European Supplies from China Facility in Apr...
2/13/2025
GSK's Mepolizumab Submits New COPD Indication for Market Approval in C...
2/13/2025
Over 30 Listed Chinese Pharma Firms Report First-Time Losses as 257 Co...
Page:
7
/
23
Total number of articles:
663
:
[First]
[<<]
[5]
[6]
[7]
[8]
[9]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit